TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Deadline Alert: Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Glancy Prongay & Murray Llp
Deadline Alert: Telix Pharmaceuticals Limited (TLX) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

Telix Pharmaceuticals faces a class action lawsuit alleging securities fraud related to misleading statements about prostate cancer therapeutic candidates and manufacturing processes, with stock price drops following SEC subpoena and FDA Complete Response Letter.

Insights
LAC   positive

Advancing domestic lithium production with a major project expected to produce 40,000 tonnes of battery-grade lithium carbonate annually, supporting electric vehicle battery manufacturing


TLX   negative

Company received SEC subpoena and FDA Complete Response Letter, experienced significant stock price drops (10.4% and 16.1%), and is accused of making materially false and misleading statements about business operations and prospects